Adrian Sandra Dobs
NationalityAmerican
Alma materCornell University (B.S., 1974),
Albany Medical College (M.D., 1978)
Scientific career
FieldsInternal Medicine, Endocrinology
InstitutionsJohns Hopkins University
Websitewww.hopkinsmedicine.org/profiles/details/adrian-dobs

Adrian Sandra Dobs is an American internal medicine and endocrinology physician, Professor of Medicine and Oncology at Johns Hopkins University, Director of the Johns Hopkins Clinical Research Network,[1] and co-director of the Johns Hopkins Center to Reduce Cancer Disparities.[2] Her clinical practice is focused on sex hormone disorders in both men and women, and her research focus is on male gonadal function particularly new forms of male hormone replacement therapy and aging.[3]

Education

Dobs received her M.D. from Albany Medical College in 1978. She completed a medical residency and was selected to be a Chief Resident at Albert Einstein College of Medicine, and completed both research and clinical fellowships in endocrinology and metabolism at Johns Hopkins Hospital.[3]

Career and research

In 2005, Dobs was promoted to Professor at Johns Hopkins University. From 2005 to 2015 she served as Vice Chair of Medicine for Faculty Development in the Department of Medicine at Johns Hopkins Hospital.[3]

Dobs' research has focused primarily on disorders of male gonadal function, with over 250 published works.[4] She has also provided opinion on clinical research in the scientific literature.[5]

Select media

  • 1995 Washington Post story "FDA Approves Patch for Low Testosterone"[6]
  • 2016 Newsweek story "Meet the Canadian Athlete Changing Sports' Attitude to Gender"[7]
  • 2019 ABC News story "Lovingly, a family raises an intersex child - again"[8]
  • 2020 NBC News story "Testosterone treatment should be given only for sexual dysfunction, guideline suggests"[9]
  • 2021 Discover article "Why It's Harder for Many Transgender People to Access (and Trust) COVID-19 Vaccines"[10]

References

  1. ↑ "About the JH Clinical Research Network". Retrieved October 29, 2021.
  2. ↑ "Adrian Sandra Dobs, M.D., M.H.S., Professor of Medicine". Johns Hopkins Medicine. Retrieved October 29, 2021.
  3. 1 2 3 "Adrian S. Dobs ICTR". Retrieved October 29, 2021.
  4. ↑ "Dobs, Adrian Sandra - Author Detail". Scopus. Retrieved October 29, 2021.
  5. ↑ Dobs, Adrian S. (August 6, 2013). "A little better than placebo is still better than nothing". Nature Medicine. 19 (8): 962. doi:10.1038/nm0813-962. ISSN 1546-170X. PMID 23921736. S2CID 28045580.
  6. ↑ Squires, Sally (October 15, 1995). "FDA Approves Patch for Low Testosterone". Washington Post. Retrieved October 30, 2021.
  7. ↑ "The legal case of a Canadian athlete could change the way sports views gender". Newsweek. February 5, 2016. Retrieved October 30, 2021.
  8. ↑ "Lovingly, a family raises an intersex child - again". ABC News. Retrieved October 30, 2021.
  9. ↑ "Testosterone treatment shouldn't be given for aging, new guideline suggests". NBC News. January 7, 2020. Retrieved October 30, 2021.
  10. ↑ "Why It's Harder for Many Transgender People to Access (and Trust) COVID-19 Vaccines". Discover Magazine. Retrieved October 30, 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.